$YDES
YD Bio Ltd
Nasdaq · Healthcare · Services-Medical Laboratories · Taipei City
YDES chart
What traders are saying about $YDES
Latest postsYD Bio Ltd news
- YD Bio Limited Estimates – NASDAQ:YDES
TradingView ·
- YD (YDES) Gains +1.39% — Support Holds at $5.56 2026-10-22 - Backspread Trade
https://www.siam.in/ ·
- YD Bio (Nasdaq:YDES) - Stock Analysis
Simply Wall Street ·
- YD Bio and EG BioMed Partner with JoiiUp to Launch AI-Driven Cancer Risk Assessment for Corporate Wellness Programs
Yahoo Finance ·
- YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment
Yahoo Finance ·
- YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
Yahoo Finance ·
- YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
Yahoo Finance ·
- YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
Yahoo Finance ·
- YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research
Yahoo Finance ·
- YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada
Yahoo Finance ·
- YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services
Yahoo Finance ·
- YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations
Yahoo Finance ·
YD Bio Ltd key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $596,817 | $510,360 | $350,131 |
| Net income | -$8.3M | -$1.4M | $13,560 |
| Diluted EPS | $-0.12 | $-0.02 | $0.00 |
| Total assets (year end) | $13.8M | $6.9M | – |
| Cash and equivalents (year end) | $6.0M | $3.1M | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 20-FANNUAL REPORT
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
About YD Bio Ltd
- Ticker
- YDES (Nasdaq)
- Industry
- Services-Medical Laboratories
- Headquarters
- Taipei City
- Incorporated in
- Cayman Islands
- Fiscal year end
- December 31
- SEC CIK
- 2011674
- Former names
- True Velocity, Inc./DE
Frequently asked questions
What exchange is YD Bio Ltd listed on?
YD Bio Ltd trades on the Nasdaq under the ticker symbol YDES.
What industry is YD Bio Ltd in?
YD Bio Ltd is classified by the SEC under "Services-Medical Laboratories", part of the Healthcare sector on StockTweeting.
Where is YD Bio Ltd headquartered?
YD Bio Ltd's business address on file with the SEC is in Taipei City.
When does YD Bio Ltd's fiscal year end?
YD Bio Ltd's fiscal year ends on December 31.
How much revenue did YD Bio Ltd report?
YD Bio Ltd reported $596,817 in revenue for calendar year 2025, according to its SEC filings.